glp 1 based drugs The GLP-1 Revolution: From Diabetes and Obesity to Alzheimer's and PCOS Ease your GLP Popular GLP-1 medications may have
Description
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial
Clues exist that may help explain the distinct results of liraglutide and exenatide
As seen for the GIP receptor knockout mice, VLP-GIP efficiently reduced body weight gain in animals on a high-fat diet (69), supporting that the GIP receptor plays a role in developing obesity
393: 248252 [DOI] [PubMed] [Google Scholar] 136.NucheBerenguer B, Moreno P, PortalNunez S, et al
Current Obesity Reports
